Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darius Moradpour

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|December 11, 2023
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis EAli Saadat, Jérôme Gouttenoire, Paolo Ripellino, et al.
Journal of Hepatology|December 3, 2014
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavageChristoph Welsch, Katrin Haselow, Jérôme Gouttenoire, et al.
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Journal of Thrombosis and Haemostasis : JTH|March 23, 2025
Effect of direct oral anticoagulants in cirrhosis: an in vitro studyCindy Pereira Portela, Debora Bertaggia Calderara, Elise Mdawar-Bailly, et al.
Journal of Hepatology|January 18, 2011
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosisTao Cai, Jean-François Dufour, Beat Muellhaupt, et al.
Journal of Virology|October 23, 2009
Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptationMaria Ripoli, Annamaria D'Aprile, Giovanni Quarato, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Plos One|July 23, 2020
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A proteaseHuong T L Tran, Kenichi Morikawa, Anggakusuma, et al.
Journal for Immunotherapy of Cancer|October 25, 2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse eventsAlexander Coukos, Julien Vionnet, Michel Obeid, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 11, 2018
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogsMaged Saleh, Christoph Welsch, Chengcong Cai, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|December 11, 2023
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis EAli Saadat, Jérôme Gouttenoire, Paolo Ripellino, et al.
Journal of Hepatology|December 3, 2014
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavageChristoph Welsch, Katrin Haselow, Jérôme Gouttenoire, et al.
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Journal of Thrombosis and Haemostasis : JTH|March 23, 2025
Effect of direct oral anticoagulants in cirrhosis: an in vitro studyCindy Pereira Portela, Debora Bertaggia Calderara, Elise Mdawar-Bailly, et al.
Journal of Hepatology|January 18, 2011
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosisTao Cai, Jean-François Dufour, Beat Muellhaupt, et al.
Journal of Virology|October 23, 2009
Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptationMaria Ripoli, Annamaria D'Aprile, Giovanni Quarato, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Plos One|July 23, 2020
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A proteaseHuong T L Tran, Kenichi Morikawa, Anggakusuma, et al.
Journal for Immunotherapy of Cancer|October 25, 2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse eventsAlexander Coukos, Julien Vionnet, Michel Obeid, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 11, 2018
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogsMaged Saleh, Christoph Welsch, Chengcong Cai, et al.
Pageof 19